1032820-95-3Relevant academic research and scientific papers
N-BENZYL PYRROLIDINE DERIVATIVES
-
Page/Page column 35, (2010/05/13)
The present invention relates to a compound of formula I wherein Ar, R1, R2, R3, n, and o are as defined herein or to a pharmaceutically active salt, a racemic mixture, an enantiomer, an optical isomer or a tautomeric form thereof. The present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS
-
Page/Page column 25, (2009/04/24)
The invention relates to a compound of general formula wherein Ar, R1, R2, R3, R4, n, o, p, s, X and are as defined herein or to a pharmaceutically active salt thereof, including all stereoisomeric forms, indivi
PYRROLIDINE DERIVATIVES AS NK2 RECEPTOR ANTAGONISTS
-
Page/Page column 28, (2009/12/27)
The present invention relates to compounds of formula I wherein R1, R2, R3, Ar and n are as defined herein and pharmaceutically active salts, racemic mixtures, enantiomers, optical isomers or tautomeric forms thereof. The compounds can be used for the treatment of depression, anxiety or schizophrenia.
